Moderna, Racing for Profits, Keeps Covid Vaccine Out of Reach of Poornews2021-10-09T15:06:57+00:00October 9th, 2021|The New York Times|
Johnson & Johnson to Seek F.D.A. Authorization for Booster Shotnews2021-10-04T17:16:18+00:00October 4th, 2021|The New York Times|
An Experimental H.I.V. Vaccine Fails in Africanews2021-08-31T11:50:11+00:00August 31st, 2021|The New York Times|
¿La vacuna Johnson & Johnson requerirá refuerzo?news2021-08-20T23:50:24+00:00August 20th, 2021|The New York Times|
What to Know About Boosters if You Got the Johnson & Johnson Vaccinenews2021-08-19T00:52:34+00:00August 19th, 2021|The New York Times|
Covid Vaccines Produced in Africa Are Being Exported to Europenews2021-08-16T15:14:18+00:00August 16th, 2021|The New York Times|
F.D.A. Aims to Give Final Approval to Pfizer Vaccine by Early Next Monthnews2021-08-04T08:25:24+00:00August 4th, 2021|The New York Times|
U.S. Authorities Seek Documents From Troubled Covid Vaccine Manufacturernews2021-07-30T22:36:19+00:00July 30th, 2021|The New York Times|
Some Are Chasing Extra Vaccine Shots, While Scientists Debatenews2021-07-30T08:57:08+00:00July 30th, 2021|The New York Times|
J&J Vaccine Shelf-Life Extended by F.D.A. to Six Monthsnews2021-07-29T08:55:50+00:00July 29th, 2021|The New York Times|